Lancet Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2000.
2000 Mumbai, Maharashtra, India Converted to LLP
Last Updated:
Access Report
About Lancet Pharma Private Limited

Lancet Pharma Private Limited, a converted to llp private limited company, was established on 20 April 2000 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24230MH2000PTC126038. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.77 Cr and a paid-up capital of ₹1.77 Cr.

Its leadership includes Srinivas Hariharan (Director), Shankar Srinivasan (Additional Director). Past directors included Rupesh Hemendra Shah. Its latest AGM occurred on 30 September 2015, with the balance sheet filed on 31 March 2015. It is based at 1St Floor, Hornby View Bldg 12, Rustom Sidhwa Marg, Fort, Mumbai, Maharashtra, 400001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH2000PTC126038

  • Registration Number

    126038

  • Incorporation Date

    20 April 2000

  • Authorized Capital

    ₹1.77 Cr

  • Paid-Up Capital

    ₹1.77 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Converted to LLP

Key Metrics
  • Authorised Capital ₹ 1.77 Cr
  • Paid Up Capital ₹ 1.77 Cr
  • Company Age 25 Year, 10 Months
  • Last Filing with ROC 31 Mar 2015
Company report

Lancet Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lancet Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lancet Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Srinivas Hariharan Director 04 Sep 2002 Current
Shankar Srinivasan Additional Director 23 Sep 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Sep 2015 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lancet Pharma.

Enhance accessibility to Lancet Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Lancet Pharma revenue growth over time
Lancet Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lancet Pharma?

Unlock access to Lancet Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Lancet Pharma?

Unlock and access historical data on people associated with Lancet Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lancet Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lancet Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lancet Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Lancet Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2015 as per latest MCA records. was documented.

  • Director Appointment

    Shankar Srinivasan was appointed as a Additional Director was appointed as a Additional Director on 23 Sep 2015 & has been associated with this company since 10 years 5 months . was recorded as a recent event.

  • Balance Sheet

    Progress on Lancet Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2015 with Roc Mumbai. was documented.

  • Director Appointment

    Srinivas Hariharan was appointed as a Director was appointed as a Director on 04 Sep 2002 & has been associated with this company since 23 years 5 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Lancet Pharma Private Limited was registered on 20 Apr 2000 with Roc Mumbai & aged 25 years 10 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lancet Pharma Private Limited?

The CIN of Lancet Pharma Private Limited is U24230MH2000PTC126038.

Where is Lancet Pharma Private Limited headquartered?

Lancet Pharma Private Limited is headquartered at 1St Floor, Hornby View Bldg 12, Rustom Sidhwa Marg, Fort, Mumbai, Maharashtra, 400001.

When was Lancet Pharma Private Limited incorporated?

Lancet Pharma Private Limited was incorporated on 20 April 2000.

Who are the current directors of Lancet Pharma Private Limited?

The current directors of Lancet Pharma Private Limited are

What is the primary industry of Lancet Pharma Private Limited?

The primary industry of Lancet Pharma Private Limited is Chemicals.

Is Lancet Pharma Private Limited a listed company?

Lancet Pharma Private Limited is unlisted.

What is the capital structure of Lancet Pharma Private Limited?

The authorized capital of Lancet Pharma Private Limited is ₹1.77 Cr, and the paid-up capital is ₹1.77 Cr.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available